These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 18277195)

  • 1. Regular exercise training compared with percutaneous intervention leads to a reduction of inflammatory markers and cardiovascular events in patients with coronary artery disease.
    Walther C; Möbius-Winkler S; Linke A; Bruegel M; Thiery J; Schuler G; Halbrecht R
    Eur J Cardiovasc Prev Rehabil; 2008 Feb; 15(1):107-12. PubMed ID: 18277195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of acute mental stress and exercise on inflammatory markers in patients with coronary artery disease and healthy controls.
    Kop WJ; Weissman NJ; Zhu J; Bonsall RW; Doyle M; Stretch MR; Glaes SB; Krantz DS; Gottdiener JS; Tracy RP
    Am J Cardiol; 2008 Mar; 101(6):767-73. PubMed ID: 18328837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of exercise capacity with high-sensitive C-reactive protein in patients with stable coronary artery disease.
    Rahimi K; Secknus MA; Adam M; Hayerizadeh BF; Fiedler M; Thiery J; Schuler G
    Am Heart J; 2005 Dec; 150(6):1282-9. PubMed ID: 16338272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exercise training modulates cytokines activity in coronary heart disease patients.
    Goldhammer E; Tanchilevitch A; Maor I; Beniamini Y; Rosenschein U; Sagiv M
    Int J Cardiol; 2005 Apr; 100(1):93-9. PubMed ID: 15820291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous coronary intervention increases leptin and decreases adiponectin levels.
    Azar RR; Sarkis A; Salameh E; Gannagé-Yared MH; Amm-Azar M; Badaoui G; Germanos M; Kassab R
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):712-6. PubMed ID: 17121520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulant and/or antiplatelet treatment in patients with atrial fibrillation after percutaneous coronary intervention. A single-center experience.
    Maegdefessel L; Schlitt A; Faerber J; Bond SP; Messow CM; Buerke M; Raaz U; Werdan K; Muenzel T; Weiss C
    Med Klin (Munich); 2008 Sep; 103(9):628-32. PubMed ID: 18813885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary excretion of nitric oxide metabolites in runners, sedentary individuals and patients with coronary artery disease: effects of 42 km marathon, 15 km race and a cardiac rehabilitation program.
    Rodriguez-Plaza LG; Alfieri AB; Cubeddu LX
    J Cardiovasc Risk; 1997; 4(5-6):367-72. PubMed ID: 9865669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of combined high-sensitive C-reactive protein and N-terminal-probrain natriuretic peptide for predicting cardiovascular events in patients with suspected coronary artery disease.
    Huang PH; Lu TM; Wu TC; Lin FY; Chen YH; Chen JW; Lin SJ
    Coron Artery Dis; 2008 May; 19(3):187-93. PubMed ID: 18418236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Training after percutaneous coronary intervention- an undervalued treatment option?].
    Munk PS; Larsen AI
    Tidsskr Nor Laegeforen; 2007 May; 127(10):1365-7. PubMed ID: 17519991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of exercise training session duration in the rehabilitation of coronary artery disease patients.
    Hansen D; Dendale P; Berger J; Onkelinx S; Reyckers I; Hermans A; Vaes J; Reenaers V; Meeusen R
    Eur J Cardiovasc Prev Rehabil; 2008 Aug; 15(4):453-9. PubMed ID: 18677171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing psychosocial stress: a novel mechanism of improving survival from exercise training.
    Milani RV; Lavie CJ
    Am J Med; 2009 Oct; 122(10):931-8. PubMed ID: 19682669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trimetazidine potentiates the effects of exercise training in patients with ischemic cardiomyopathy referred for cardiac rehabilitation.
    Belardinelli R; Lacalaprice F; Faccenda E; Volpe L
    Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):533-40. PubMed ID: 18797405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary artery bypass surgery versus percutaneous coronary artery intervention in patients on chronic hemodialysis: does a drug-eluting stent have an impact on clinical outcome?
    Manabe S; Shimokawa T; Fukui T; Fumimoto KU; Ozawa N; Seki H; Takanashi S
    J Card Surg; 2009; 24(3):234-9. PubMed ID: 19438773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence, predictors, and outcomes of post-percutaneous coronary intervention nephropathy in patients with diabetes mellitus and normal baseline serum creatinine levels.
    Roy P; Raya V; Okabe T; Pinto Slottow TL; Steinberg DH; Smith K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Lindsay J; Waksman R
    Am J Cardiol; 2008 Jun; 101(11):1544-9. PubMed ID: 18489931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of serum levels of inflammatory markers and allelic variant of interleukin-6 in patients with acute coronary syndrome and stable angina pectoris.
    Ozdemir O; Gundogdu F; Karakelleoglu S; Sevimli S; Pirim I; Acikel M; Arslan S; Serdar S
    Coron Artery Dis; 2008 Feb; 19(1):15-9. PubMed ID: 18281810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous coronary angioplasty compared with exercise training in patients with stable coronary artery disease: a randomized trial.
    Hambrecht R; Walther C; Möbius-Winkler S; Gielen S; Linke A; Conradi K; Erbs S; Kluge R; Kendziorra K; Sabri O; Sick P; Schuler G
    Circulation; 2004 Mar; 109(11):1371-8. PubMed ID: 15007010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes of plasma high-sensitive C-reactive protein and monocyte chemotactic factor-1 following percutaneous coronary interventional procedures in patients with coronary artery disease].
    Wang SL; Han YL; Liu LJ; Yan CH; Kang J
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):1073-5. PubMed ID: 18583268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the systemic levels of inflammatory markers after percutaneous coronary intervention with bare metal versus sirolimus-eluting stents.
    Rebeiz AG; Zoghbi E; Harb R; Youhanna S; Skouri HN; Dimassi A; Abou-Nader G; Nasrallah A; Sawaya J; Gharzuddine W; Alam S
    J Interv Cardiol; 2009 Apr; 22(2):169-74. PubMed ID: 19245380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress and inflammation due to peripheral polymorphonuclear leukocytes after coronary angiography vs percutaneous coronary intervention.
    Farah R; Shurtz-Swirski R; Bolotin Y; Brezins M
    Minerva Cardioangiol; 2008 Apr; 56(2):189-95. PubMed ID: 18319697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Myonecrosis and inflammatory response following percutaneous coronary angioplasty. A protective role for betablockers?].
    Radulescu B; Morel O; Faure A; Jesel L; Roul G; Chauvin M; Ohlmann P; Bareiss P
    Ann Cardiol Angeiol (Paris); 2009 Feb; 58(1):27-33. PubMed ID: 18656848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.